Company / Book Value per Share
Inhibikase Therapeutics, Inc. Book Value per Share History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$1.775
FY2024
5-year range
$0.973 / $4.98
FY2021-FY2024
Trend
-64.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $1.527 to $1.775 over the past 2 years.
Based on SEC 10-K filings.
$1.775 in FY2024 with a 3-year CAGR of +22.2%.
Improved from $1.527 to $1.775 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +22.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +22.2%, indicating consistent growth.
- In FY2024, book value per share decreased 64.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.775 | -64.4% |
| FY2023 | $4.98 | +226.1% |
| FY2022 | $1.527 | +56.9% |
| FY2021 | $0.973 | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026